Found: 10
Select item for more details and to access through your institution.
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Skin care management in cancer patients: an evaluation of quality of life and tolerability.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Unanticipated toxicities from anticancer therapies: survivors' perspectives.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Dermatologic challenges in cancer patients and survivors.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Search for evidence-based approaches for the prevention and palliation of hand--foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs)
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The growing importance of skin toxicity in EGFR inhibitor therapy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article